Last reviewed · How we verify
NCT05498831: SUURGE
Evaluation of a New Pain Management Protocol Involving Intranasal Sufentanil in the Emergency Room.
trial testing Pain assessment at 15 minutes, 30 minutes, 60 minutes, 120 minutes after initial assessment by the triage nurse in Acute Pain in 245 participants. Completed in 23 February 2023.
23 February 2023
Quick facts
| Lead sponsor | Groupe Hospitalier de la Region de Mulhouse et Sud Alsace |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 245 |
| Start date | 9 August 2022 |
| Primary completion | 23 February 2023 |
| Estimated completion | 23 February 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Pain assessment at 15 minutes, 30 minutes, 60 minutes, 120 minutes after initial assessment by the triage nurse
Conditions studied
- Acute Pain — all drugs for Acute Pain →
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Who can join
18 and older, any sex, with Acute Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Until now, the Mulhouse emergency department used a protocol for severe pain based on morphine titration. In order to relieve patients' pain more quickly, a new protocol was implemented based on the use of intranasal sufentanil. The primary objective of the study is to prospectively assess the efficacy of the new pain management protocol implemented in the emergency department and based on intranasal sufentanil in combination with paracetamol and codeine for pain of moderate intensity and intranasal sufentanil in combination with paracetamol followed by morphine titration for severe pain. This new pain management protocol has been updated as part of the upcoming French High Authority for Health hospital certification, for which pain management is one of the priority criteria. This research does not change the routine care given to the patient.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05498831
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Pain
Currently open trials in the same condition.
- NCT06779604 — Dexmedetomidine and Dexamethasone Added as Adjuvant Infraclavicular Brachial Plexus Block in Upper Limb Surgery · recruiting
- NCT07348419 — Quadro-Iliac vs Thoracolumbar Interfascial Plane Block for Analgesia After Single-Level Lumbar Disc Surgery · NA · recruiting
- NCT07335159 — Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention · NA · recruiting
- NCT07348523 — Comparison of the Postoperative Analgesic Efficacy of Classical and Modified Erector Spinae Plane Blocks After Lumbar Sp · NA · recruiting
- NCT07336264 — Characterization of Acute Pain · recruiting
Other Groupe Hospitalier de la Region de Mulhouse et Sud Alsace trials
Trials by the same sponsor.
- NCT07344350 — A Non-randomised, Non-inferiority Comparative Study of Oral Actiskenan (Morphine Sulfate) Versus Intranasal Sufentanil i · not yet recruiting
- NCT07250217 — Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients · NA · recruiting
- NCT06399094 — Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients Wit · terminated
- NCT06460441 — Comparison of the SUNRISE© Device With Ventilatory Polygraphy for the Diagnosis of Obstructive Sleep Apnea Hypopnea Synd · completed
- NCT05835908 — Follow-up of Patients Referred to Unscheduled Care Centers by the Emergency Call Center in the Haut-Rhin Department, Fra · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05498831 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
- Last refreshed: 30 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05498831.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing